Literature DB >> 30899362

CLIC1 promotes the progression of oral squamous cell carcinoma via integrins/ERK pathways.

Jiali Feng1,2,3, Jie Xu1,2,3, Ying Xu1,2,3, Jun Xiong1,2,3, Tingting Xiao1,2,3, Chao Jiang1,2,3, Xian Li1,2,3, Qian Wang1,2,3, Jie Li1,2,3, Yong Li1,2,3.   

Abstract

Chloride intracellular channel 1 (CLIC1), a member of the chloride channel protein family, acts as a promoter in many malignancies, but its role in oral cancer remains unclear. Hence, this research aimed to explore the effects of CLIC1 on the progression of oral cancer cells in vitro, and we assessed its role in cell proliferation, apoptosis, migration, invasion, angiogenesis, and chemosensitivity to cisplatin and possible signaling pathways. The results demonstrated that CLIC1 depletion inhibited the proliferation, invasion, migration and angiogenesis of oral squamous cell carcinoma (OSCC) cells in vitro, but promoted cell apoptosis and increased the drug susceptibility to cisplatin. In contrast, CLIC1 upregulation was positively correlated with cell proliferation, invasion and migration and angiogenesis. Mechanistically, CLIC1 silencing decreased the levels of ITGαv, ITGβ1, p-ERK, vimentin, MMP2 and MMP9, and increased the levels of p-p38, E-cadherin, caspase3 and caspase9. CLIC1 overexpression enhanced the ITGαv, ITGβ1, p-ERK, vimentin, MMP2 and MMP9 levels and decreased E-cadherin expression. Overall, these results indicated that CLIC1 promotes the progression of OSCC, and we speculated that its potential mechanism may be related to the regulation of ITGαv and ITGβ1, which led to activation of the MAPK/ERK and MAPK/p38 signal pathways.

Entities:  

Keywords:  CLIC1; Integrin; OSCC; apoptosis; migration; pathways

Year:  2019        PMID: 30899362      PMCID: PMC6413291     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  7 in total

Review 1.  Chloride intracellular channel 1 promotes esophageal squamous cell carcinoma proliferation via mTOR signalling.

Authors:  Huiwu Geng; Cheng Feng; Zhangran Sun; Xu Fan; Yiqing Xie; Jinghua Gu; Libin Fan; Gang Liu; Chao Li; Rick F Thorne; Xu Dong Zhang; Xinying Li; Xiaoying Liu
Journal:  Transl Oncol       Date:  2022-10-14       Impact factor: 4.803

2.  CLIC1 knockout inhibits invasion and migration of gastric cancer by upregulating AMOT-p130 expression.

Authors:  Y Qiu; Y-T Mao; J-H Zhu; K Zhao; J-F Wang; J-M Huang; G-Q Chang; Y-T Guan; F-Y Huang; Y-J Hu; J-Q Chen; J-L Liu
Journal:  Clin Transl Oncol       Date:  2020-07-13       Impact factor: 3.405

3.  Acetylation-stabilized chloride intracellular channel 1 exerts a tumor-promoting effect on cervical cancer cells by activating NF-κB.

Authors:  Wanyue Wang; Xin Li; Ye Xu; Weikang Guo; Hui Yu; Lu Zhang; Yaoxian Wang; Xiuwei Chen
Journal:  Cell Oncol (Dordr)       Date:  2021-01-19       Impact factor: 6.730

4.  Construction for Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Human Retinal Detachment (RD) with Proliferative Vitreoretinopathy (PVR).

Authors:  Ke Yao; Yixian Yu; Hong Zhang
Journal:  Med Sci Monit       Date:  2020-02-27

5.  Chlorine, chromium, proteins of oxidative stress and DNA repair pathways are related to prognosis in oral cancer.

Authors:  Aricia Leone Evangelista Monteiro de Assis; Anderson Barros Archanjo; Raul C Maranhão; Suzanny O Mendes; Rafael P de Souza; Rafael de Cicco; Mayara M de Oliveira; Aline R Borçoi; Lucas de L Maia; Fabio D Nunes; Marcelo Dos Santos; Leonardo O Trivilin; Christiano J G Pinheiro; Adriana M Álvares-da-Silva; Breno Valentim Nogueira
Journal:  Sci Rep       Date:  2021-11-16       Impact factor: 4.379

Review 6.  MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy.

Authors:  Yuxi Cheng; Juan Chen; Yuxin Shi; Xiaodan Fang; Zhangui Tang
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

7.  WNT7A Promotes EGF-Induced Migration of Oral Squamous Cell Carcinoma Cells by Activating β-Catenin/MMP9-Mediated Signaling.

Authors:  Hui Xie; Yadong Ma; Jun Li; Huixia Chen; Yongfu Xie; Minzhen Chen; Xuyang Zhao; Sijie Tang; Shuo Zhao; Yujie Zhang; Jun Du; Feimin Zhang; Luo Gu
Journal:  Front Pharmacol       Date:  2020-02-26       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.